The absence of insider buying at Catalyst Pharmaceuticals ov...

The absence of insider buying at Catalyst Pharmaceuticals over the past year is concerning. However, the high level of insider ownership indicates alignment with shareholder interests. Insider selling, even below the current price, raises questions about their view on the company's valuation.